Adverum Biotechnologies
ADVM
#9323
Rank
โ‚น8.45 B
Marketcap
โ‚น382.96
Share price
2.16%
Change (1 day)
-20.52%
Change (1 year)

Revenue for Adverum Biotechnologies (ADVM)

Revenue in 2025 (TTM): โ‚น83.82 Million

According to Adverum Biotechnologies 's latest financial reports the company's current revenue (TTM ) is โ‚น89.89 Million. In 2024 the company made a revenue of โ‚น85.78 Million a decrease over the revenue in the year 2023 that were of โ‚น0.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adverum Biotechnologies from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น83.82 M-2.28%
2024 โ‚น85.78 M-71.38%
2023 โ‚น0.29 B
2022 N/A-100%
2021 โ‚น0.55 B
2020 N/A-100%
2019 โ‚น17.82 M-84.18%
2018 โ‚น0.11 B-4.53%
2017 โ‚น0.11 B19.4%
2016 โ‚น98.87 M-35.84%
2015 โ‚น0.15 B325.1%
2014 โ‚น36.25 M
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA